Pro-inflammatory cytokines IL6, TNF-α, IL1β, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis

Journal of Infection

Volumn 55, Issue 3, 2007, Pages 220-225

  Watkin, R W ^a   Harper, L V ^b   Vernallis, A B ^b   Lang, S ^c   Lambert, P A ^b   Ranasinghe, A M ^a   Elliott, T S J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

^c GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Acute phase proteins; Cytokines; Infective endocarditis; Inflammatory markers

Indexed keywords

ACUTE PHASE PROTEIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; ENTEROCOCCUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART VALVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; STAPHYLOCOCCUS AUREUS;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CARRIER PROTEINS; ENDOCARDITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTEIN PRECURSORS; REAGENT KITS, DIAGNOSTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547851204     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.05.174     Document Type: Article

References (31)

1. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 3 (1994) 200-209
2. Lamas C.C., and Eykyn S.J. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis 25 3 (1997) 713-719
3. Li J.S., Sexton D.J., Mick N., Nettles R., Flower V., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 4 (2000) 633-638
4. Lang S., Watkin R.W., Lambert P.A., Littler W.A., Bonser R.S., and Elliott T.S. Evaluation of PCR in the molecular diagnosis of endocarditis. J Infect 48 3 (2004) 269-275
5. Mandell G.L., Douglas J.E.B., and Dolin R. Principles and practice of infectious diseases. 5th ed. (2000), Churchill Livingstone
6. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 389 (1982) 39-48
7. Sullivan G.W., and Mandell G.L. The role of cytokines in infection. Curr Opin Infect Dis 4 (1991) 344-349
8. Vassalli P. The pathophysiology of tumour necrosis factor. Annu Rev Immunol 10 (1992) 411-452
9. Kern W.V., Engel A., Scheieffer S., Prummer O., and Kern P. Circulating tumour necrosis factor alpha (TNF), soluble TNF receptors, and interleukin 6 in human bacterial endocarditis. Infect Immun 61 12 (1993) 5413-5416
10. Whicher J., Bienvenu J., and Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 38 (2001) 483-493
11. Mirjam C.-C., and Muller B. Procalcitonin in bacterial infections - hype, hope, more or less. Swiss Med Wkly 135 (2005) 451-460
12. Schumann R.R., and Zweigner J. A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 37 3 (1999) 271-274
13. Blairon L., Wittebole X., and Laterre P. Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to Gram-positive and fungal infections. J Infect Dis 187 (2003) 287-291
14. Rawczynska-Englert I., Hryniewiecki T., and Dzierzanowska D. Evaluation of serum cytokine concentrations in patients with infective endocarditis. J Heart Valve Dis 9 5 (2000) 705-709
15. Alter P., Hoeschen J., Ritter M., and Maisch B. Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. Am J Cardiol 89 12 (2002) 1400-1404
16. Capo C., Zugun F., Stein A., Tardei G., Lepedi H., and Raoult D. Upregulation of tumour necrosis factor alpha and interleukin-1 beta in Q fever endocarditis. Infect Immun 64 5 (1996) 1638-1642
17. Meuller C., Huber P., Laifer G., Meuller B., and Perruchoud A.P. Procalcitonin and the early diagnosis of infective endocarditis. Circulation 109 (2004) 1707-1710
18. Kocazeybek B., Kucukoglu S., and Oner Y.A. Procalcitonin and C-reactive protein in infective endocarditis: correlations with etiology and prognosis. Chemotherapy 49 (2003) 76-84
19. Christ-Crain M., and Muller B. Procalcitonin in bacterial infections - hype, hope, more or less?. Swiss Med Wkly 135 (2005) 451-460
20. Albillos A., De la Hera A., and Alverez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 363 9421 (2004) 1608-1610
21. Roder B.L., Wandall D.A., Frimodt-Moller N., Espersen F., Skinhoj P., and Rosdahl V.T. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 159 5 (1999) 462-469
22. Widemar E., Que Y.A., Entenza J.M., and Moreillon P. New concepts in the pathophysiology of infective endocarditis. Curr Infect Dis Rep 8 4 (2006) 271-279
23. Kaplanski G., Granel B., Vaz T., and Durand J.M. Jarisch-Herxheimer reaction complicating the treatment of chronic Q fever endocarditis: elevated TNFalpha and IL-6 serum levels. J Infect 37 1 (1998) 83-84
24. Onagawa T. Staphylococcal a toxin synergistically enhances inflammation caused by bacterial components. FEMS Immunol Med Microbiol 33 (2002) 15-21
25. Sinha B., Francois P., Que Y., Hussain M., Heilmann C., Morellon P., et al. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun 68 12 (2000) 6871-6878
26. Hogevik H., Olaison L., Andersson R., and Alestig K. C-reactive protein is more sensitive than erythrocyte sedimentation rate for diagnosis of infective endocarditis. Infection 25 2 (1997) 82-85
27. Patrick L., and Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Altern Med Rev 6 3 (2001) 248-271
28. Watkin R.W., Lang S., Smith J.M., Elliott T.S.J., and Littler W.A. Role of troponin I in active infective endocarditis. Am J Cardiol 94 9 (2004) 1198-1199
29. Mold C., and Du Clos T.W. C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fc gamma receptors. J Immunol 176 12 (2006) 7598-7604
30. Kitsis R.N., and Jialal I. Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein. N Engl J Med 355 5 (2006) 513-515
31. Kratz A., Ferraro M., Sluss P.M., and Lewandrowski K.B. Case records for the Massachusetts General Hospital. Weekly clinicopathological excercises. Laboratory reference values. N Engl J Med 351 15 (2004) 1548-1563